Last updated: Oct 30, 2026, 12:00 AM

Corvus Pharmaceuticals Inc Exchange (NASDAQ, USD)

CRVS

10.03
-0.08 (-0.76%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
45.95%
3 year return (CAGR)
104.05%
5 year return (CAGR)
17.73%
10 year return (CAGR)
-3.66%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
879.06M
Price/Sales
-
Ent value
874.10M
Price/Book
3.90
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-1.18%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open10.54
Daily high10.61
Daily low10.33
Daily Volume981K
All-time high25.52
1y analyst estimate33.14
Beta0.86
EPS (TTM)-0.59
Dividend per share0.00
Ex-div date-
Next earnings date5 Mar 2026

Ready to capitalize on Corvus Pharmaceuticals Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
CRVSS&P500
Current price drop from All-time high-60.70%-3.00%
Highest price drop-96.97%-56.47%
Date of highest drop28 Mar 20239 Mar 2009
Avg drop from high-68.55%-10.65%
Avg time to new high95 days12 days
Max time to new high2216 days1805 days